AusTrakka: Fast-tracking nationalized genomics surveillance in response to the COVID-19 pandemic

Tuyet Hoang; Anders Gonçalves da Silva; Amy V. Jennison; Deborah A. Williamson; Benjamin P. Howden; Torsten Seemann

doi:10.1038/s41467-022-28529-9

AusTrakka: Fast-tracking nationalized genomics surveillance in response to the COVID-19 pandemic

Tuyet Hoang, Anders Gonçalves da Silva, Amy V. Jennison, Deborah A. Williamson, Benjamin P. Howden^*, Torsten Seemann

^*Corresponding author for this work

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Article number	865
Journal	Nature Communications
Volume	13
Issue number	1
DOIs	https://doi.org/10.1038/s41467-022-28529-9
Publication status	Published - 14 Feb 2022

Access to Document

10.1038/s41467-022-28529-9Licence: CC BY

Cite this

@article{0f47a2e76a9846fbae66cdca08dffb29,

title = "AusTrakka: Fast-tracking nationalized genomics surveillance in response to the COVID-19 pandemic",

author = "Tuyet Hoang and {da Silva}, {Anders Gon{\c c}alves} and Jennison, {Amy V.} and Williamson, {Deborah A.} and Howden, {Benjamin P.} and Torsten Seemann",

note = "The authors gratefully acknowledge the contributions from all Communicable Diseases Genomics Network (CDGN) laboratory members, the broader AusTrakka team in Victoria, New South Wales and Queensland and the AusTrakka development team. This work is funded by the Australian Government Department of Health (B.P.H.), the Victorian Government Department of Health (B.P.H.), a National Health and Medical Research Council Fellowship (GNT1196103) (B.P.H.) and the Medical Research Future Fund (FSPGN000049) (A.V.J., D.A.W., T.S. and B.P.H.). Extended COVID-19 Laboratory Members of the Communicable Diseases Genomics Network (CDGN) include: Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity; The Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity; Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia; Virology Research Laboratory, Serology and Virology Division, NSW Health Pathology, Prince of Wales Hospital, Randwick, NSW, Australia; Department of Infectious Disease and Microbiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Public Health Microbiology and Virology, Forensic and Scientific Services, Queensland Department of Health, Brisbane, QLD, Australia; Public Health Laboratory, Microbiology and Infectious Diseases, SA Pathology, Adelaide, SA, Australia; Department of Microbiology, PathWest Laboratory Medicine, QEII Medical Centre, Perth, WA, Australia; Royal Hobart Hospital, Hobart, TAS, Australia; ACT Pathology, ACT, Australia; Research Biology School, Australian National University, Canberra, ACT, Australia; Pathology, Royal Darwin Hospital, Darwin, NT, Australia; The Institute of Environmental Science and Research, New Zealand.",

year = "2022",

month = feb,

day = "14",

doi = "10.1038/s41467-022-28529-9",

language = "English",

volume = "13",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Nature publishing group",

number = "1",

}

TY - JOUR

T1 - AusTrakka

T2 - Fast-tracking nationalized genomics surveillance in response to the COVID-19 pandemic

AU - Hoang, Tuyet

AU - da Silva, Anders Gonçalves

AU - Jennison, Amy V.

AU - Williamson, Deborah A.

AU - Howden, Benjamin P.

AU - Seemann, Torsten

N1 - The authors gratefully acknowledge the contributions from all Communicable Diseases Genomics Network (CDGN) laboratory members, the broader AusTrakka team in Victoria, New South Wales and Queensland and the AusTrakka development team. This work is funded by the Australian Government Department of Health (B.P.H.), the Victorian Government Department of Health (B.P.H.), a National Health and Medical Research Council Fellowship (GNT1196103) (B.P.H.) and the Medical Research Future Fund (FSPGN000049) (A.V.J., D.A.W., T.S. and B.P.H.). Extended COVID-19 Laboratory Members of the Communicable Diseases Genomics Network (CDGN) include: Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity; The Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity; Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia; Virology Research Laboratory, Serology and Virology Division, NSW Health Pathology, Prince of Wales Hospital, Randwick, NSW, Australia; Department of Infectious Disease and Microbiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia; Public Health Microbiology and Virology, Forensic and Scientific Services, Queensland Department of Health, Brisbane, QLD, Australia; Public Health Laboratory, Microbiology and Infectious Diseases, SA Pathology, Adelaide, SA, Australia; Department of Microbiology, PathWest Laboratory Medicine, QEII Medical Centre, Perth, WA, Australia; Royal Hobart Hospital, Hobart, TAS, Australia; ACT Pathology, ACT, Australia; Research Biology School, Australian National University, Canberra, ACT, Australia; Pathology, Royal Darwin Hospital, Darwin, NT, Australia; The Institute of Environmental Science and Research, New Zealand.

PY - 2022/2/14

Y1 - 2022/2/14

U2 - 10.1038/s41467-022-28529-9

DO - 10.1038/s41467-022-28529-9

M3 - Comment/debate

C2 - 35165271

AN - SCOPUS:85124599872

SN - 2041-1723

VL - 13

JO - Nature Communications

JF - Nature Communications

IS - 1

M1 - 865

ER -